carbamazepine has been researched along with Muscular Atrophy, Spinal in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine is a drug commonly used in the treatment of neuropathic pain." | 1.29 | Carbamazepine-induced hepatitis in a patient with cervical myelopathy. ( Kong, KH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, KH | 1 |
| Serratrice, G | 1 |
| Pouget, J | 1 |
| Pellissier, JF | 1 |
| Cros, D | 1 |
1 review available for carbamazepine and Muscular Atrophy, Spinal
| Article | Year |
|---|---|
[Carbamazepine-sensitive neuromyotonia and Charcot-Marie-Tooth disease of the neuronal type].
Topics: Adolescent; Carbamazepine; Charcot-Marie-Tooth Disease; Humans; Male; Muscular Atrophy, Spinal; Neur | 1989 |
1 other study available for carbamazepine and Muscular Atrophy, Spinal
| Article | Year |
|---|---|
Carbamazepine-induced hepatitis in a patient with cervical myelopathy.
Topics: Aged; Carbamazepine; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Eruptions; Eosinophil | 1996 |